FABP1 and metabolic syndrome: This study demonstrated that FABP1 in the XXZ group of patients with acute ischemic stroke was predominantly associated with the “cellular lipid metabolic process” and “response to lipid,” aligning with both domestic and international research on FABP1 and dyslipidemia.